The Class I recall status indicates that the product poses a risk of causing serious health consequences or death if consumed ...

A production issue raised concerns that ink printing on some cups could run when exposed to high temperatures, inspectors ...

Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s ...

Your morning coffee ritual is usually a simple pleasure, but a recent recall of certain coffee pods might make you ...

Class II recalls from the FDA indicate a potential risk to consumer safety where use or exposure to the product may cause ...

Nirwana Foods recalls 28-oz golden raisins for undeclared sulfites that could cause life-threatening allergic reactions.

FDA issues warning letters to distributors of food, dietary supplements and unapproved drugs that contain ...

Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...

New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.

The FDA asked Sarepta Therapeutics to halt shipments of its Elevidys gene therapy after a patient's death linked to a similar treatment. Sarepta will continue shipments for ambulatory patients but ...

From AI-powered inspections to bold regulatory shifts on dyes and sugar, the FDA has made waves in 2025. Here are the 17 most impactful stories shaping the future of food regulation.

Warehouses must be registered, handlers trained, and hygiene audits uploaded, the FSSAI CEO said at a meeting with over 70 ...